Significantly, overexpression of Hemgn has been observed in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and may confer resistance to chemotherapy (26, 27, 28, 29). Here, HEMGN is linked to acute myeloid leukemia.